EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101

Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775

The polycomb group protein EZH2 is involved in progression of prostate cancer

Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717

The regulation of E2F by pRB-family proteins.

Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580

Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex

Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A. K., Wild, B., Miller, E., O’Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,553

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites

Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,536

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

Pollack, J. R., Sørlie, T., Perou, C. M., Rees, C. A., Jeffrey, S. S., Lønning, P. E., Tibshirani, R. J., Botstein, D., Børresen‐Dale, A., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162471999 · Cited by 1,167

Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a

Uchiyama, N., Tanaka, Y., & Kawamoto, T. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.023 · Cited by 25

Regulation of Polycomb Repression by O-GlcNAcylation: Linking Nutrition to Epigenetic Reprogramming in Embryonic Development and Cancer

Decourcelle, A., Leprince, D., & Dehennaut, V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00117 · Cited by 25

AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition

Zhang, K., Shen, Q., Fang, Y., Sun, Y.-M., Ding, J., & Chen, Y. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0248-2 · Cited by 25

UvKmt6-mediated H3K27 trimethylation is required for development, pathogenicity, and stress response in Ustilaginoidea virens

Meng, S., Liu, Z., Shi, H., Wu, Z., Qiu, J., Wen, H., Lin, F., Tao, Z., Luo, C., & Kou, Y. (2021) · Virulence · doi:10.1080/21505594.2021.2008150 · Cited by 25

Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes

Barrand, S., Andersen, I. S., & Collas, P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.116 · Cited by 24

p16INK4a‐mediated suppression of telomerase in normal and malignant human breast cells

Bazarov, A. V., van Sluis, M., Hines, W. C., Bassett, E., Beliveau, A., Campeau, E., Mukhopadhyay, R., Lee, W. J., Melodyev, S., Zaslavsky, Y., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00599.x · Cited by 25

Cross-species analyses unravel the complexity of H3K27me3 and H4K20me3 in the context of neural stem progenitor cells

Rhodes, C. T., Sandstrom, R. S., Huang, S.-W. A., Wang, Y., Schotta, G., Berger, M. S., & Lin, C. A. (2016) · Neuroepigenetics · doi:10.1016/j.nepig.2016.04.001 · Cited by 26

GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells

Xu, H., Zhang, L., Qian, X., Zhou, X., Yan, Y., Zhou, J., Ge, W., Albahde, M. A. H., & Wang, W. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7845 · Cited by 24

Association of TGFβ signaling with the maintenance of a quiescent stem cell niche in human oral mucosa

Andl, C. D., Bras, G. F. L., Loomans-Kropp, H. A., Kim, A. S., Zhou, L., Zhang, Y., & Andl, T. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1473-0 · Cited by 24

EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features

Liu, Y., Yu, K., Li, M., Zeng, K., Wei, J., Li, X., Liu, Y., Zhao, D., Fan, L., Yu, Z., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.04.011 · Cited by 25

Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib

Yu, Y., Liao, H., Xie, R., Zhang, Y., Zheng, R., Chen, J., & Zhang, B. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.590813 · Cited by 24

EZH2, an on–off valve in signal network of tumor cells

Sun, S., Feng, Y., Zhang, L., & Zhou, X. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.004 · Cited by 24

Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma

Rizk, M., Rizq, O., Oshima, M., Nakajima‐Takagi, Y., Koide, S., Saraya, A., Isshiki, Y., Chiba, T., Yamazaki, S., Ma, A., et al. (2019) · Cancer Science · doi:10.1111/cas.14207 · Cited by 24

Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types

Shan, S. W., Tang, F. M. K., Chow, P. H., Maroto, M., Cai, D. Q., & Lee, K. K. (2007) · PROTEOMICS · doi:10.1002/pmic.200700636 · Cited by 24

Polycomb group molecule PHC3 regulates polycomb complex composition and prognosis of osteosarcoma

Iwata, S., Takenobu, H., Kageyama, H., Koseki, H., Ishii, T., Nakazawa, A., Tatezaki, S., Nakagawara, A., & Kamijo, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01586.x · Cited by 24

Regulation of histone H3K27 methylation in inflammation and cancer

Ma, J., Zhang, Y., Li, J., Dang, Y., & Hu, D. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00254-x · Cited by 28

Enhancer of Zeste Homolog 2 Expression Is Associated With Tumor Cell Proliferation and Invasion in Cervical Cancer

Fang, J., Li, Q., & Zhang, M. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821335a9 · Cited by 23

PRC2 loss amplifies Ras signaling in cancer

Baude, A., Lindroth, A. M., & Plass, C. (2014) · Nature Genetics · doi:10.1038/ng.3124 · Cited by 23

Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells

Chien, Y., Chen, J., Chen, Y.-H., Chou, R., Lee, H.-C., & Yu, Y. (2020) · Cancers · doi:10.3390/cancers12071781 · Cited by 23

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)

April-Monn, S., Andreasi, V., Lena, M. S., Sadowski, M. C., Kim‐Fuchs, C., Buri, M. C., Ketkar, A., Maire, R., Domenico, A. D., Schrader, J., et al. (2021) · Cancers · doi:10.3390/cancers13195014 · Cited by 23

Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition

Cheng, Y.-C., Zhang, Y., Tripathi, S., Harshavardhan, B., Jolly, M. K., Schiebinger, G. R., Levine, H., McDonald, T. O., & Michor, F. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406842121 · Cited by 25

HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells

Li, C., Tsai, H.-H., Ko, C., Pan, Y.-C., Yen, C.-J., Lai, H.-Y., Yuh, C., Wu, W.-C., & Wang, J. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0025 · Cited by 23

Drosophila RB Proteins Repress Differentiation-Specific Genes via Two Different Mechanisms

Lee, H., Ohno, K., Voskoboynik, Y., Ragusano, L., Martinez, A., & Dimova, D. K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01075-09 · Cited by 26

The knock-down of overexpressed EZH2 and BMI-1 does not prevent osteosarcoma growth

Setoguchi (2010) · Oncology Reports · doi:10.3892/or_00000684 · Cited by 23

Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology

Billingsley, K. J., Manca, M., Gianfrancesco, O., Collier, D. A., Sharp, H. M., Bubb, V. J., & Quinn, J. P. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.036 · Cited by 24

Gene Signature of Proliferating Human Pancreatic α Cells

Gutiérrez, G. D., Xin, Y., Okamoto, H., Kim, J., Lee, A., Ni, M., Adler, C., Yancopoulos, G. D., Murphy, A. J., & Gromada, J. (2018) · Endocrinology · doi:10.1210/en.2018-00469 · Cited by 22

The Role of RB in Prostate Cancer Progression

Burkhart, D. L., Morel, K. L., Sheahan, A. V., Richards, Z. A., & Ellis, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_13 · Cited by 24

Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention

Tellez, C. S., Picchi, M. A., Juri, D. E., Do, K., Desai, D. H., Amin, S., Hutt, J. A., Filipczak, P. T., & Belinsky, S. A. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01034-4 · Cited by 23

Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer

Bachmann, N., Hoegel, J. J., Haeusler, J., Kuefer, R., Herkommer, K., Paiss, T., Vogel, W., & Maier, C. (2005) · The Prostate · doi:10.1002/pros.20296 · Cited by 23

Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors

Wassef, M. A., Michaud, A., & Margueron, R. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1208872 · Cited by 25

High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not

Findeis-Hosey, J. J., Huang, J., Li, F., Yang, Q., McMahon, L. A., & Xu, H. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.019 · Cited by 22

Polycomb protein EZH2 expression in diffuse large B-cell lymphoma is associated with better prognosis in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone

Lee, H. J., Shin, D. H., Kim, K. B., Shin, N., Park, W. Y., Lee, J. H., Choi, K. U., Kim, J. Y., Lee, C. H., & Sol, M. Y. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.858816 · Cited by 24

Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression

Kopparapu, P. K., Bhoi, S., Mansouri, L., Arabanian, L. S., Plevová, K., Pospı́šilová, Š., Wasik, A. M., Croci, G. A., Sander, B., Paulli, M., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1164375 · Cited by 22

Chromatin organization changes during the establishment and maintenance of the postmitotic state

Ma, Y., & Buttitta, L. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0159-8 · Cited by 22

Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-κB/EZH2/YY1 axis in early-stage colon cancers

Huang, H., Chao, C.-C., Wu, P., Chung, H., Lee, H.-Y., Suen, C., Hwang, M., Cai, B., & Kannagi, R. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.01.002 · Cited by 22

EZH2 reduction is an essential mechanoresponse for the maintenance of super-enhancer polarization against compressive stress in human periodontal ligament stem cells

Li, Q., Sun, X., Tang, Y., Qu, Y., Zhou, Y., & Zhang, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02963-3 · Cited by 22

DIST: spatial transcriptomics enhancement using deep learning

Zhao, Y., Wang, K., & Hu, G. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad013 · Cited by 22

UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma

Abali, G. K., Zhang, Y., Szeto, P., Zhao, P., Masoumi-Moghaddam, S., Fedele, C. G., Leece, I., Huang, C., Cheung, J. G., Ameratunga, M., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02631-8 · Cited by 24

Polycomb and the Emerging Epigenetics of Pancreatic Cancer

Grzenda, A. L., Ördög, T., & Urrutia, R. A. (2011) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-011-9262-4 · Cited by 25

Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications

Lee, C., & Kim, J. K. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30022 · Cited by 22

EZH2 Polycomb Transcriptional Repressor Expression Correlates with Methylation of the APAF-1 Gene in Superficial Transitional Cell Carcinoma of the Bladder

Hinz, S., Kempkensteffen, C., Weikert, S., Schostak, M., Schrader, M., Miller, K., & Christoph, F. (2007) · Tumor Biology · doi:10.1159/000103380 · Cited by 21

HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia

He, Z., Zhang, S., Ma, D., Fang, Q., Yang, L., Shen, S., Chen, Y., Ren, L., & Wang, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2115-9 · Cited by 21

The PRC2 complex directly regulates the cell cycle and controls proliferation in skeletal muscle

Adhikari, A., & Davie, J. K. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1806448 · Cited by 23

Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer

Loras, A., Segovia, C., & Ruiz-Cerdá, J. L. (2021) · Cancers · doi:10.3390/cancers13112719 · Cited by 23

EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes

Huang, Y., Durall, R. T., Luong, N. M., Hertzler, H. J., Huang, J. H., Gokhale, P. C., Leeper, B. A., Persky, N. S., Root, D. E., Anekal, P. V., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1475 · Cited by 21

Beyond the tail: the consequence of context in histone post-translational modification and chromatin research

Weinzapfel, E. N., Fedder-Semmes, K. N., Sun, Z., & Keogh, M. (2024) · Biochemical Journal · doi:10.1042/bcj20230342 · Cited by 23

Single agent‐ and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells

Michaelsen, S. R., Christensen, C. L., Sehested, M., Cramer, F., Poulsen, T. T., Patterson, A. V., & Poulsen, H. S. (2012) · The Journal of Gene Medicine · doi:10.1002/jgm.2630 · Cited by 21

Expression of polycomb protein EZH2 in multi‐stage tissues of gastric carcinogenesis

Gan Hui, C. A. I., Ke, W. A. N. G., Miao, Q., Peng, Y. S., & Chen, X. Y. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00420.x · Cited by 21

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions

Inari, H., Suganuma, N., Kawachi, K., Yoshida, T., Yamanaka, T., Nakamura, Y., Yoshihara, M., Nakayama, H., Yamanaka, A., Masudo, K., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3154-3 · Cited by 21

Chromatin Modification and Senescence: Linkage by Tumor Suppressors?

Han, X., Berardi, P., & Riabowol, K. T. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.69 · Cited by 20

Tumor suppression by the histone demethylase UTX

Tsai, M.-C., Wang, J. K., & Chang, H. Y. (2010) · Cell Cycle · doi:10.4161/cc.9.11.11845 · Cited by 21

Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer

Maylin, Z. R., Smith, C. D., Classen, A., Asim, M., Pandha, H., & Wang, Y. Z. (2024) · Cells · doi:10.3390/cells13231999 · Cited by 21

Epigenetic regulation and mechanobiology

Li, S., Yang, D., Gao, L., Wang, Y., & Qin, P. (2020) · Biophysics Reports · doi:10.1007/s41048-020-00106-x · Cited by 20

Mallory–Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells

French, B. A., Oliva, J., Bardag‐Gorce, F., Li, J., Zhong, J., Buslon, V. S., & French, S. W. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.02.003 · Cited by 20

Inhibition of Methyltransferases Accelerates Degradation of cFLIP and Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis

Braun, F., Mathur, R., Sehgal, L., Wilkie-Grantham, R. P., Chandra, J., Berkova, Z., & Samaniego, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117994 · Cited by 20

Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system

Unland, R., Kerl, K., Schlosser, S., Farwick, N., Plagemann, T., Lechtape, B., Clifford, S. C., Kreth, J. H., Gerß, J., Mühlisch, J., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1313-1 · Cited by 20

Multimodal Regulation Orchestrates Normal and Complex Disease States in the Retina

Olivares, A. M., Jelcick, A. S., Reinecke, J. B., Leehy, B. D., Haider, A., Morrison, M. A., Cheng, L. Z., Chen, D. F., DeAngelis, M. M., & Haider, N. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-00788-3 · Cited by 20

Expression of EZH2 in uveal melanomas patients and associations with prognosis

Cheng, Y., Li, Y., Huang, X., Wei, W., & Qu, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19462 · Cited by 20

SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications

Trieu, V., Aulet, R. M., Ciolino, A. L., & Rimash, T. (2019) · Annals of Otology Rhinology & Laryngology · doi:10.1177/0003489419836668 · Cited by 20

Chemogenomics for drug discovery: clinical molecules from open access chemical probes

Quinlan, R. B. A., & Brennan, P. E. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00016k · Cited by 18

15 Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and the Polycomb Repressive Complex 2

Pasini, D., Hansen, K. H., Christensen, J. H., Agger, K., Cloos, P. A., & Helin, K. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.001165_27.x · Cited by 20

A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells

Poulsen, T. T., Pedersen, N. M., Juel, H. B., & Poulsen, H. S. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.24 · Cited by 20

pRb-E2F signaling in life of mesenchymal stem cells: Cell cycle, cell fate, and cell differentiation

Popov, B. V., & Ns, P. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.007 · Cited by 21

Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities

Zhang, J., Zeng, X., Guo, Q., Sheng, Z., Chen, Y., Wan, S., Zhang, L., & Zhang, P. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00548-w · Cited by 21

The role of Sp1 and EZH2 in the regulation of LMX1A in cervical cancer cells

Lin, W., Yan, M., Yu, P., Li, H., Kuo, C.-C., Hsu, C., & Lin, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.020 · Cited by 19

Polycomb and Trithorax Group Proteins: The Long Road from Mutations in Drosophila to Use in Medicine

Chetverina, D., Ломаев, Д. В., & Erokhin, M. (2020) · Acta Naturae · doi:10.32607/actanaturae.11090 · Cited by 18

Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types

Erokhin, M., Chetverina, O., Győrffy, B., Tatarskiy, V. V., Mogila, V., Shtil, A. A., Roninson, I. B., Moreaux, J., Georgiev, P. G., Cavalli, G., et al. (2021) · Cancers · doi:10.3390/cancers13133155 · Cited by 19

Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer

Dong, G., Xu, J., Qi, Y.-R., Yuan, Z., & Zhao, W. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179574 · Cited by 21

β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer

Mohan, D. R., Borges, K. S., Finco, I., LaPensee, C. R., Rege, J., Solon, A. L., Little, D. W., Else, T., Almeida, M. Q., Dang, D., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2712 · Cited by 20

EZH2 silencing by RNA interference inhibits proliferation in bladder cancer cell lines

Zhang, Y. B., Niu, H., Chang, J., Dong, G., & MA, X. B. (2010) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2009.01148.x · Cited by 19

Icilin inhibits E2F1-mediated cell cycle regulatory programs in prostate cancer

Lee, S., Chun, J. N., Kim, S.-H., So, I., & Jeon, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.015 · Cited by 19

Urothelial Cancer Stem Cells

Dimov, I., Višnjić, M., & Stefanović, V. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.138 · Cited by 19

Definition of Genetic Events Directing the Development of Distinct Types of Brain Tumors from Postnatal Neural Stem/Progenitor Cells

Hertwig, F., Meyer, K., Braun, S. B., Ek, S., Spang, R., Pfenninger, C. V., Artner, I., Prost, G., Chen, X., Biegel, J. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3525 · Cited by 19

Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis

Guo, L., Yang, T., Liang, S.-C., Guo, J.-X., & Wang, Q. (2014) · Tumor Biology · doi:10.1007/s13277-014-1888-y · Cited by 19

Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.

Shiogama, S., Yoshiba, S., Soga, D., Motohashi, H., & Shintani, S. (2013) · PubMed · Cited by 19

Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network

Signaroldi, E., Laise, P., Cristofanon, S., Brancaccio, A., Reisoli, E., Atashpaz, S., Terreni, M. R., Doglioni, C., Pruneri, G., Malatesta, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms10753 · Cited by 19

Polycomb repressor complex 2 function in breast cancer (Review)

Martin, C., & Moorehead, R. A. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5122 · Cited by 21

Advanced neuroendocrine prostate tumors regress to stemness

Ellis, L., & Loda, M. F. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519151112 · Cited by 19

Altered epigenetic signals in human disease

Croce, L. D., Buschbeck, M., Gutiérrez, A., Joval, I., Morey, L., Villa, R., & Minucci, S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.9.1103 · Cited by 19

Surveillance of Retroelement Expression and Nucleic‐Acid Immunity by Histone Methyltransferase SETDB1

Kang, Y. (2018) · BioEssays · doi:10.1002/bies.201800058 · Cited by 18

Effect of EZH2 on pulmonary artery smooth muscle cell migration in pulmonary hypertension

Wang, Y., Huang, X., Leng, D., Li, J., Liang, Y., & Jiang, T. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11768 · Cited by 18

Genes and pathways involved in senescence bypass identified by functional genetic screens

Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 18

The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer

Lu, S., Ding, X., Wang, Y., Hu, X., Sun, T., Wei, M., Wang, X., & Wu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.772542 · Cited by 18

Senescence-associated exosomes transfer miRNA-induced fibrosis to neighboring cells

Lee, A. H., Ghosh, D., Koh, I. L., & Dawson, M. (2023) · Aging · doi:10.18632/aging.204539 · Cited by 20

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors

Kim, H., Lebeau, B., Papadopoli, D. J., Jovanović, P., Russo, M. D. S. T., Avizonis, D. Z., Morita, M., Afzali, F., Ursini‐Siegel, J., Postovit, L.-M. M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109188 · Cited by 17

The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy

Pathania, A. S., Chava, H., Balusu, R., Pasupulati, A. K., Coulter, D. W., & Challagundla, K. B. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200785 · Cited by 19

The role of polycomb repressive complexes in biliary tract cancer

Mayr, C., Neureiter, D., Wagner, A., Pichler, M., & Kiesslich, T. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.986460 · Cited by 18

EZH2 is highly expressed in pituitary adenomas and associated with proliferation

Schult, D., Hölsken, A., Siegel, S., Buchfelder, M., Fahlbusch, R., Kreitschmann‐Andermahr, I., & Buslei, R. (2015) · Scientific Reports · doi:10.1038/srep16965 · Cited by 18

The Role of Histone Methyltransferases and Long Non-coding RNAs in the Regulation of T Cell Fate Decisions

Gaballa, J. M., Neto, M. B. B., Ramos, G. P., Bamidele, A. O., Gonzalez, M. M., Sagstetter, M. R., Sarmento, O. F., & Faubion, W. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02955 · Cited by 18

Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease

Xu, J., Xue, C., Wang, X., Zhang, L., Mei, C., & Mao, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.921631 · Cited by 17

Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma

Durand, M.-A., Drouin, A., Mouchard, A., Durand, L., Esnault, C., Berthon, P., Tallet, A., Corre, Y. L., Hainaut‐Wierzbicka, E., Blom, A., et al. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.02.038 · Cited by 17

Uropathogenic E.coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2)

Ting, K. K. Y., AITKEN, K. J., Penna, F. J., Samiei, A., Sidler, M., Jiang, J.-X., Ibrahim, F., Tölg, C., Delgado-Olguı́n, P., Rosenblum, N. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149118 · Cited by 17

DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations

Akpa, C. A., Kleo, K., Lenze, D., Oker, E., Dimitrova, L., & Hummel, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220681 · Cited by 17

Co-Regulation of Histone-Modifying Enzymes in Cancer

Islam, A. B. M. M. K., Richter, W. F., Jacobs, L. A., López-Bigas, N., & Benevolenskaya, E. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024023 · Cited by 17

EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease

Lv, J., Lan, B., Fu, L., He, C., Zhou, W., Wang, X., Zhou, C., Mao, Z., Chen, Y., Mei, C., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05785-5 · Cited by 16

Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma

Nguyen, V. T. M., Namba, H., Porter, H., Shlyueva, D., López, E., Melcher, A. A., Béguelin, W., Melnick, A. M., & Helin, K. (2025) · Blood · doi:10.1182/blood.2024026534 · Cited by 16

Hepatitis B virus X protein regulates the mEZH2 promoter via the E2F1-binding site in AML12 cells

Shi, X., Zhang, Y., Zhou, X., Lu, J., Guo, Z., & Huang, P. (2011) · 癌症：英文版 · doi:10.5732/cjc.010.10437 · Cited by 16

Epigenetic silencing and activation of transcription: influence on the radiation sensitivity of glioma cell lines

Sak, A., Kübler, D., Bannik, K., Groneberg, M., Strunz, S., Kriehuber, R., & Stuschke, M. (2017) · International Journal of Radiation Biology · doi:10.1080/09553002.2017.1270472 · Cited by 16

The Research Progress of EZH2 Genes in Tumors

Hong-me, W. (2014) · Medical Recapitulate

Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements

Tonini, T., D’Andrilli, G., Fucito, A., Gaspa, L., & Bagella, L. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21241 · Cited by 75

The role of the polycomb group protein EZH2 in the molecular pathogenesis of prostate cancer

Bryant, R. J. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)

Roles of EZH2 Histone Methyltransferase in Tumorigenesis

We, D. (2011) · Journal of International Obstetrics and Gynecology

EZH2: Not EZHY (Easy) to Deal

Deb, G., Singh, A. K., & Gupta, S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0546 · Cited by 110